Approvals/TGA/PIQRAY alpelisib 250 mg daily dose blister (200+50 mg tablet) composite pack

Approved

STANDARD

PIQRAY alpelisib 250 mg daily dose blister (200+50 mg tablet) composite pack

Approval Id: 8203873d7e24eea9
Product Name: PIQRAY alpelisib 250 mg daily dose blister (200+50 mg tablet) composite pack
Artg Id: 315055
Artg Name: PIQRAY alpelisib 250 mg daily dose blister (200+50 mg tablet) composite pack
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2020-03-20
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/eed3c978a3eb97bc88a273c287882d72.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/f3fd71fa20944ddd5abbf10be22f3f3c.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

8203873d7e24eea9

Type

Standard